Market Place
Sourcing Support
All News #Library
Biotech
At AACR IO Meeting: Ankyra Therapeutics Unveils ANK-203 Data
18 Feb 2026 //
BUSINESSWIRE
Ankyra Names Sailaja Battula, Phd Chief Scientific Officer
15 Dec 2025 //
BUSINESSWIRE
Ankyra Therapeutics Launches Phase 1b Lung Cancer Trial
17 Nov 2025 //
BUSINESSWIRE
Ankyra To Present Phase 1 Clinical Data At SITC Annual Meeting
04 Nov 2025 //
BUSINESSWIRE
Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting
28 Apr 2025 //
BUSINESSWIRE
Ankyra Doses First Visceral Tumor Patient in Phase 1 ANCHOR Trial
05 Nov 2024 //
BUSINESSWIRE
Ankyra`s ANK-101 Phase 1 Amendment, ASCO Trial In Progress Presentation
01 Jun 2024 //
BUSINESSWIRE
Ankyra Announces First Patient Dosed in Phase 1 Trial Evaluating ANK-101
05 Mar 2024 //
BUSINESSWIRE
Ankyra Announces Trial Agreement with Regeneron to Evaluate ANK-101
13 Nov 2023 //
BUSINESSWIRE
Ankyra Receives FDA IND and Health Canada CTA Approval to Advance ANK-101
24 Oct 2023 //
BUSINESSWIRE
Ankyra Announces Clinical Trial Collaboration and Supply Agreement with Merck
04 Oct 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.